Sartorius Stedim Biotech S.A. (DIM.PA) stock analysis

In our weekly check, Sartorius Stedim Biotech S.A. is graded C (A to F). Of 25 checks on debt, profit, cash flow and trend: 13 pass, warnings: 6, red flags: 6.

About Sartorius Stedim Biotech S.A.

Sartorius Stedim Biotech S.A. is a Healthcare company (Medical - Instruments & Supplies) based in France, listed on PAR as DIM.PA.

What our checks show for DIM.PA

Red flags

• The net margin fell by 3.8 points over 5 years, to 10.6%: the company keeps less of each sale as profit.
• The gross margin fell by 9.2 points, to 44.6%: costs are rising faster than prices.
• Revenue fell 4.3% a year over the last 3 years.
• The price is 63.1 times earnings (P/E): the market already pays for a lot of future growth.
• The stock has fallen as much as 77% from a peak. Would you have held through that?
• Thinly traded (about 90 thousand shares a day): buying and selling can move the price.

Warning signs

• Operating profit covers interest only 3.8 times: a weak year could make the payments hard.
• Earnings per share fell 29.4% a year over the last 3 years.
• Net profit fell 28.2% a year over the last 3 years.
• The price swings a lot: 40.3% annual volatility. Expect large ups and downs.
• Recovering from its deepest fall took about 2.5 years.
• Return on capital (ROCE) is only 8.6%.

Strengths

• Operating cash flow is 1.91x net profit: the profit arrives as real cash.
• Analysts expect earnings per share to grow about 40.2% a year over the next years.
• Analysts expect the net margin to improve by 7.2 points from today's 10.6%.
• The dividend takes 21% of profit: there is a cushion.
• A large company: market value $22.94 billion.
• Pay in shares is only 0% of free cash flow.

Similar companies

STMN.SW · WST · FPH.NZ · SOLV · MDLN · BAX

Questions

What grade does Sartorius Stedim Biotech S.A. (DIM.PA) have?

In our weekly check, Sartorius Stedim Biotech S.A. is graded C (A to F). Of 25 checks on debt, profit, cash flow and trend: 13 pass, warnings: 6, red flags: 6. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of DIM.PA stock?

This week's biggest flags for Sartorius Stedim Biotech S.A.: Margins falling, Gross margin falling, Weak revenue growth. In total 12 of 25 checks show a warning or a red flag.

What does Sartorius Stedim Biotech S.A. do?

Sartorius Stedim Biotech S.A. is a Healthcare company (Medical - Instruments & Supplies) based in France, listed on PAR as DIM.PA.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-24

Open the full analysis